Liver cancer represents the third leading cause of cancer-related death worldwide. Cholangiocarcinoma (CCA) is the second most common type of liver cancer after hepatocellular carcinoma, accounting for 10-15% of all primary liver malignancies. Both the incidence and mortality of CCA have been steadily increasing during the last decade. Moreover, most CCAs are diagnosed at an advanced stage, when therapeutic options are very limited.
Cholangiocarcinoma
Sarcognato, Samantha;Sacchi, Diana;Fassan, Matteo;Fabris, Luca;Cadamuro, Massimiliano;Zanus, Giacomo;Cataldo, Ivana;Cacciatore, Matilde;Guido, Maria
2021
Abstract
Liver cancer represents the third leading cause of cancer-related death worldwide. Cholangiocarcinoma (CCA) is the second most common type of liver cancer after hepatocellular carcinoma, accounting for 10-15% of all primary liver malignancies. Both the incidence and mortality of CCA have been steadily increasing during the last decade. Moreover, most CCAs are diagnosed at an advanced stage, when therapeutic options are very limited.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
252-Article Text-3557-1-10-20210709.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Creative commons
Dimensione
3.63 MB
Formato
Adobe PDF
|
3.63 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
